4893 items matching your search terms.

A metanalysis of alternative schedule of temozolomide in recurrent malignant glioma

Khasraw, M Brown, C Ashley, DM Rosenthal, MA

Practicalities of developing a breast magnetic resonance imaging screening service for women at high risk for breast cancer

Kiely, BE Hossack, LK Shadbolt, CL Davis, A Cassumbhoy, R Moodie, K Antill, Y Mitchell, G
ANZ JOURNAL OF SURGERY, 2011     DOI:10.1111/j.1445-2197.2010.05581.x

ANZ1001 SORBET: Study of Oestrogen Receptor Beta and Efficacy of Tamoxifen—a single-arm, phase II study of the efficacy of tamoxifen in triple-negative but estrogen receptor beta-positive metastatic breast cancer

Kiely, BE Phillips, K Francis, PA Boyle, FM Forbes, JF Fox, SB Murphy, L Gebski, V Lindsay, DF Sutherland, RL Badger, H

How long have I got? Estimating typical, best-case, and worst-case scenarios for patients starting first-line chemotherapy for metastatic breast cancer: a systematic review of recent randomized trials

Kiely, BE Soon, YY Tattersall, MHN Stockler, MR
JOURNAL OF CLINICAL ONCOLOGY, 2011     DOI:10.1200/JCO.2010.30.2174

Thinking and talking about life expectancy in incurable cancer

Kiely, BE Stockler, MR Tattersall, MHN

Life after adjuvant chemotherapy for breast cancer: the news is mostly good

Kiely, BE Wilcken, NRC Stockler, MR
JOURNAL OF CLINICAL ONCOLOGY, 2011     DOI:10.1200/JCO.2010.33.5588

Prevention of osteoporosis as a consequence of aromatase inhibitor therapy in postmenopausal women with early breast cancer: Rationale and design of a randomized controlled trial

Kilbreath, S Refshauge, KM Beith, J Ward, L Sawkins, K Paterson, R Clifton-Bligh, P Sambrook, PN Simpson, JM Nery, L
CONTEMPORARY CLINICAL TRIALS, 2011     DOI:10.1016/j.cct.2011.04.012

Safety and efficacy of pregabalin in patients with central post-stroke pain

Kim, JS Bashford, G Murphy, TK Martin, A Dror, V Cheung, R
PAIN, 2011     DOI:10.1016/j.pain.2010.12.023

Inconsistent quality of reporting of searching clinical trials registries in Cochrane systematic reviews and protocols

Ko, H Tai, FM Ghersi, D Askie, LM

Systematic review of safety checklists for use by medical care teams in acute hospital settings - limited evidence of effectiveness

Ko, H Turner, T Finnigan, M
BMC HEALTH SERVICES RESEARCH, 2011     DOI:10.1186/1472-6963-11-211

Randomized controlled trial of laparoscopic approach to carcinoma of the endometrium (LACE): Prevalence and risk factors for surgical complications

Kondalsamy-Chennakesavan, S Janda, M Gebski, V Nicklin, J Jobling, T Land, R Manolitass, T McCartney, A Perrin, L Obermair, A

Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study

Kurtz, JE Kaminsky, MC Floquet, A Veillard, AS Kimmig, R Dorum, A Elit, L Buck, M Petru, E Reed, N Sambia, G Varsellona, N Brown, C Pujade-Lauraine, E on behalf of Gynecologic Cancer Intergroup,
ANNALS OF ONCOLOGY, 2011     DOI:10.1093/annonc/mdr001

Early decline in cancer antigen 125 as a surrogate for progression-free survival in recurrent ovarian cancer

Lee, CK Friedlander, M Brown, C Gebski, VJ Georgoulopoulos, A Vergote, I Pignata, S Donadello, N Schmalfeldt, B Delva, R Mirza, MR Sauthier, P Pujade-Lauraine, E Lord, SJ Simes, RJ
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011     DOI:10.1093/jnci/djr282

Carboplatin-paclitaxel induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer patients treated in the CALYPSO GCIG trial

Lee, C Friedlander, M Gurney, H Brown, C Tulunay, G Belau, A Mäenpää, J Bacon, M Vasey, P Wolfram, G Reed, N Sorio, R Donadello, N Pujade-Lauraine, E Lord, S Simes, J

A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancer

Lee, C. Hudson, M. Stockler, M. Coates, A. Ackland, S. Gebski, V. Lord, S. Friedlander, M. Boyle, F. Simes, R.
BREAST CANCER RESEARCH AND TREATMENT, 2011     DOI:10.1007/s10549-011-1471-9